Stability-indicating method for simultaneous estimation of olmesartan medoxomile, amlodipine besylate and hydrochlorothiazide by RP-HPLC in tablet dosage form

Journal of Chromatographic Science

Volumn 50, Issue 8, 2012, Pages 680-687

  Jain, P S ^a   Patel, M K ^a   Gorle, A P ^a   Chaudhari, A J ^a   Surana, S J ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; HYDROCHLOROTHIAZIDE; IMIDAZOLE DERIVATIVE; OLMESARTAN; TETRAZOLE DERIVATIVE;

ARTICLE; CHEMISTRY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; REPRODUCIBILITY; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; TABLET;

AMLODIPINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; DRUG STABILITY; HYDROCHLOROTHIAZIDE; IMIDAZOLES; LINEAR MODELS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TABLETS; TETRAZOLES;

EID: 84866329873     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/bms067     Document Type: Article

References (20)

1. Sellin, L., Stegbauer, J., Laeis, P., Rump, L.C.; Adding hydrochlorothiazide to olmesartan dose dependently improves 24-h blood pressure and response rates in mild- to- moderate hypertension; Journal of Hypertension, (2005); 23: 2083-2092. (Pubitemid 41830405)
2. Sharma, R.N., Pancholi, S.S.; Validated stability indicating LC-DAD method for determination of olmesartan medoxomil in tablets exposed to stress conditions; Acta Pharmaceutica Sciencia, (2009); 51: 323-331.
3. Ashok Kumar, J., Sathya, A., Senthil Kumar, K., Patil, S.N., Prathap, B., Lokesh, S.B., et al.; Simultaneous estimation of olmesartan medoxomil and hydrochlorothiazide by RP-HPLC method from combined dosage forms; International Journal of Research in Pharmaceutical Sciences, (2010); 1(1): 24-27.
4. Rote, A.R., Bari, P.D.; Spectrophotometric estimation of olmesartan medoxomile and hydrochlorothiazide in tablet dosage form; Indian Journal of Pharmaceutical Sciences, (2010); 72(1): 111-113.
5. Kamblea, A.Y., Mahadika, M.V., Khatala, L.D., Dhaneshwara, S.R.; Validated HPLC and HPTLC method for simultaneous quantitation of amlodipine besylate and olmesartan medoxomil in bulk drug and formulation; Analytical Letters, (2010); 43: 251-258.
6. British Pharmacopoeia, Volume I, London; Her Majesty's Stationary Office, London, (2008), p. 137.
7. Budavan, S. (ed). The Merck index: An encyclopedia of chemicals, drugs & biologicals, 13th edition. Merck & Co., Whitehouse Station, NJ, (2001), p. 86.
8. Hoffman, B.B.; Therapy of hypertension. In Brunton, L.L., Lazo, J.S., Parker, K.L. (eds). Pharmacological basis of therapeutics, 11th edition. McGraw-Hill Medical, New York, NY, (2006), p. 845-868.
9. Sweetman, S.C. (ed). Martindale: The complete drug reference, 33rd edition. Pharmaceutical Press, London, (2002), p. 862.
10. Ramadan, N.K., Mohamed, H.M., Moustafa, A.A.; Rapid and highly sensitive HPLC and TLC methods for quantitation of amlodipine besylate and valsartan in bulk powder and in pharmaceutical dosage forms and in human plasma; Analytical Letters, (2010); 43: 570-581.
11. Safeer, K., Anbarasi, B., Senthilkumar, N.; Analytical method development and validation of amlodipine and hydrochlorothiazide in combined dosage form by RP-HPLC; International Journal of ChemTech Research, (2010); 2(1): 21-25.
12. Chitlange, S.S., Bagri, K., Sakarkar, D.M.; Stability indicating RPHPLC method for simultaneous estimation of valsartan and amlodipine in capsule formulation; Asian Journal of Research in Chemistry, (2008); 1(1): 15-18.
13. Shah, D.A., Bhatt, K.K., Mehta, R.S., Baldania, S.L., Gandhi, T.R.; Stability indicating RP-HPLC estimation of atorvastatin calcium and amlodipine besylate in pharmaceutical formulations; Indian Journal of Pharmaceutical Sciences, (2008); 70(6): 754-760.
14. Younus, M., Reddy, T.K., Reddy, Y.R., Arif, M.F.; RP-HPLC method development and validation for simultaneous estimation of amlodipine besylate, valsartan and hydrochlorothiazide in tablet dosage form; Journal of Pharmaceutical Research, (2010); 3(11): 2647-2650.
15. Government of India, Ministry of Wealth and Family Welfare; Indian Pharmacopoeia, Vol. II. The Controller of Publication, New Delhi, India, (2011), pp. 806, 1451.
16. Jayaseelan, S., Rajasekar, M., Ganesh, S., Sekar, V., Perumal, P.; RP-HPLC method development and validation for simultaneous estimation of losartan potassium, amlodipine besilate and hydrochlorthiazide in tablet dosage form; Pharmaceutical Chemistry, (2010); 2(3): 31-36.
17. Daniels, S.L., Vandervielen, A.J.; Stability-indicating assay for hydrochlorothiazide; Journal of Pharmaceutical Sciences, (2006); 70(2): 211-215.
18. Bhavar, G.B., Chatpalliwar, V.A., Patil, D.D., Surana, S.J.; Validated HPTLC method for simultaneous determination of quinapril hydrochloride and hydrochlorothiazide in a tablet dosage form; Indian Journal of Pharmaceutical Sciences, (2008); 70(4): 529-531.
19. International Conference on Harmonization; ICH guidelines Q2A, Text on Validation of analytical procedures. Geneva, (1994).
20. International Conference on Harmonization; ICH guidelines Q2B, Validation of analytical Procedures: Methodology. Geneva, (1996).